Skip to main content
Oncology Letters logoLink to Oncology Letters
. 2022 May 31;24(1):237. doi: 10.3892/ol.2022.13357

MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression

Ying Ye, Juhua Zhuang, Guoyu Wang, Saifei He, Jing Ni, Wei Xia
PMCID: PMC9185160  PMID: 35720496

Oncol Lett 14: 7799–7806, 2017; DOI: 10.3892/ol.2017.7201

Following the publication of this paper, it was drawn to the Editors’ attention by a concerned reader that certain of the cell migration and invasion assay data shown in Figs. 2C and 4C were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Oncology Letters, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.


Articles from Oncology Letters are provided here courtesy of Spandidos Publications

RESOURCES